Skip to Content

INCY 20 (Jakafi 20 mg)

Generic Name: ruxolitinib

Pill with imprint INCY 20 is White, Capsule-shape and has been identified as Jakafi 20 mg. It is supplied by Incyte Corporation.

Jakafi is used in the treatment of myelofibrosis; myeloproliferative disorders; polycythemia vera and belongs to the drug class multikinase inhibitors. Risk cannot be ruled out during pregnancy. Jakafi 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for INCY 20

Jakafi 20 mg INCY 20

Jakafi

Generic Name:
ruxolitinib
Imprint:
INCY 20
Strength:
20 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Incyte Corporation
Inactive Ingredients:
microcrystalline cellulose
lactose monohydrate
silicon dioxide
hydroxypropyl cellulose
povidone
sodium starch glycolate type A potato
magnesium stearate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide